A detailed history of Bsw Wealth Partners transactions in Novo Nordisk A S stock. As of the latest transaction made, Bsw Wealth Partners holds 9,296 shares of NVO stock, worth $803,360. This represents 0.12% of its overall portfolio holdings.

Number of Shares
9,296
Previous 9,083 2.35%
Holding current value
$803,360
Previous $1.08 Million 26.09%
% of portfolio
0.12%
Previous 0.16%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$85.0 - $120.04 $18,105 - $25,568
213 Added 2.35%
9,296 $799,000
Q3 2024

Oct 29, 2024

BUY
$119.07 - $145.42 $43,936 - $53,659
369 Added 4.23%
9,083 $1.08 Million
Q2 2024

Jul 16, 2024

BUY
$122.71 - $146.91 $5,153 - $6,170
42 Added 0.48%
8,714 $1.24 Million
Q1 2024

Apr 23, 2024

SELL
$102.11 - $135.92 $103,335 - $137,551
-1,012 Reduced 10.45%
8,672 $1.11 Million
Q4 2023

Jan 25, 2024

SELL
$87.78 - $105.45 $3,686 - $4,428
-42 Reduced 0.43%
9,684 $1 Million
Q3 2023

Oct 27, 2023

BUY
$90.94 - $199.54 $426,963 - $936,840
4,695 Added 93.32%
9,726 $884,000
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $1,403 - $1,553
9 Added 0.18%
5,031 $814,000
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $12,836 - $15,436
-97 Reduced 1.89%
5,022 $799,000
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $35,072 - $46,282
342 Added 7.16%
5,119 $692,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $455,152 - $558,574
4,777 New
4,777 $476,000
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $249,932 - $282,581
-3,727 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $27,408 - $31,660
429 Added 13.01%
3,727 $260,000
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $210,049 - $231,585
3,298 New
3,298 $229,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $195B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bsw Wealth Partners Portfolio

Follow Bsw Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Bsw Wealth Partners with notifications on news.